drugset / Trial / NCT01491113

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

NCT01491113

Phase 4 Completed 30 enrolled UCB Pharma Parexel · collab
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is a human pharmacology, single-dose study to investigate the pharmacokinetics of orally administered Levetiracetam (LEV) in Japanese subjects with normal renal function and in Japanese subjects with various degrees of impaired renal function.

Timeline

Start
2011-11
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 250 mg Oral
Subject Levetiracetam Other / unclassified 500 mg Oral